Jacob Bell
New Member
Author(s) Scuderi C, Filippis DD, Iuvone T, Blasio A, Steardo A, Esposito G
Institution Department of Physiology and Pharmacology 'V. Erspamer', Sapienza University of Rome, Italy.
Source Phytother Res 2008 Oct 9.
Abstract Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis sativa. It displays a plethora of actions including anticonvulsive, sedative, hypnotic, antipsychotic, antiinflammatory and neuroprotective properties. However, it is well established that CBD produces its biological effects without exerting significant intrinsic activity upon cannabinoid receptors. For this reason, CBD lacks the unwanted psychotropic effects characteristic of marijuana derivatives, so representing one of the bioactive constituents of Cannabis sativa with the highest potential for therapeutic use.The present review reports the pharmacological profile of CBD and summarizes results from preclinical and clinical studies utilizing CBD, alone or in combination with other phytocannabinoids, for the treatment of a number of CNS disorders. Copyright (c) 2008 John Wiley & Sons, Ltd.
Language ENG
Pub Type(s) JOURNAL ARTICLE
PubMed ID 18844286
Source: Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders
Institution Department of Physiology and Pharmacology 'V. Erspamer', Sapienza University of Rome, Italy.
Source Phytother Res 2008 Oct 9.
Abstract Cannabidiol (CBD) is the main non-psychotropic component of the glandular hairs of Cannabis sativa. It displays a plethora of actions including anticonvulsive, sedative, hypnotic, antipsychotic, antiinflammatory and neuroprotective properties. However, it is well established that CBD produces its biological effects without exerting significant intrinsic activity upon cannabinoid receptors. For this reason, CBD lacks the unwanted psychotropic effects characteristic of marijuana derivatives, so representing one of the bioactive constituents of Cannabis sativa with the highest potential for therapeutic use.The present review reports the pharmacological profile of CBD and summarizes results from preclinical and clinical studies utilizing CBD, alone or in combination with other phytocannabinoids, for the treatment of a number of CNS disorders. Copyright (c) 2008 John Wiley & Sons, Ltd.
Language ENG
Pub Type(s) JOURNAL ARTICLE
PubMed ID 18844286
Source: Cannabidiol in medicine: a review of its therapeutic potential in CNS disorders
